False equivalence: differences in the <i>in vitro</i> activity of ampicillin–sulbactam and amoxicillin–clavulanate in several Enterobacterales species
The high prevalence of SAM-not susceptible, AMC-susceptible isolates supports reporting AST results for both SAM and AMC to maximize options for antimicrobial therapy and to support antimicrobial stewardship.
Authors
- Michael J. Satlin (ORCID: https://orcid.org/0000-0003-4711-5334)
- Lars F. Westblade (ORCID: https://orcid.org/0000-0003-3079-7674)
- Sarah M. Russell (ORCID: https://orcid.org/0000-0001-5826-9641)
- S. Schrader (ORCID: https://orcid.org/0000-0002-9943-4727)
- Yanbin Kuang (ORCID: https://orcid.org/0000-0003-3041-7854)
- Sandra Nora González Díaz (ORCID: https://orcid.org/0000-0002-3612-0042)
- Bulent Oral
- Carmela Bacani
Institutions
- Brigham and Women's Hospital (US)
- Cornell University (US)
- New York Hospital Queens (US)
- Massachusetts General Hospital (US)
- Presbyterian Hospital (US)
- Tri-Institutional PhD Program in Chemical Biology (US)
- Weill Cornell Medicine (US)
Publication Details
- Journal
- JAC-Antimicrobial Resistance
- Published
- 2025-09-03
- DOI
- https://doi.org/10.1093/jacamr/dlaf147
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Melinta Therapeutics
- National Institutes of Health
- Weill Cornell Medical College
- Weill Cornell Medicine
- National Institute of General Medical Sciences
- National Institute of Allergy and Infectious Diseases